nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylprednisolone—CYP3A4—Thiotepa—sarcoma	0.136	0.202	CbGbCtD
Methylprednisolone—ABCB1—Dactinomycin—sarcoma	0.109	0.162	CbGbCtD
Methylprednisolone—ABCB1—Mitoxantrone—sarcoma	0.0975	0.145	CbGbCtD
Methylprednisolone—ABCB1—Vincristine—sarcoma	0.0671	0.0996	CbGbCtD
Methylprednisolone—ABCB1—Etoposide—sarcoma	0.0615	0.0913	CbGbCtD
Methylprednisolone—CYP3A4—Mitoxantrone—sarcoma	0.0584	0.0867	CbGbCtD
Methylprednisolone—ABCB1—Doxorubicin—sarcoma	0.042	0.0623	CbGbCtD
Methylprednisolone—CYP3A4—Vincristine—sarcoma	0.0402	0.0597	CbGbCtD
Methylprednisolone—CYP3A4—Etoposide—sarcoma	0.0369	0.0547	CbGbCtD
Methylprednisolone—CYP3A4—Doxorubicin—sarcoma	0.0251	0.0373	CbGbCtD
Methylprednisolone—Discomfort—Mitoxantrone—sarcoma	0.000505	0.00155	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Vincristine—sarcoma	0.000503	0.00154	CcSEcCtD
Methylprednisolone—Infection—Vincristine—sarcoma	0.0005	0.00153	CcSEcCtD
Methylprednisolone—Dyspepsia—Thiotepa—sarcoma	0.0005	0.00153	CcSEcCtD
Methylprednisolone—Thrombophlebitis—Doxorubicin—sarcoma	0.000497	0.00152	CcSEcCtD
Methylprednisolone—Increased appetite—Epirubicin—sarcoma	0.000495	0.00152	CcSEcCtD
Methylprednisolone—Blood alkaline phosphatase increased—Doxorubicin—sarcoma	0.000495	0.00152	CcSEcCtD
Methylprednisolone—Diabetes mellitus—Doxorubicin—sarcoma	0.000495	0.00152	CcSEcCtD
Methylprednisolone—Confusional state—Mitoxantrone—sarcoma	0.000494	0.00151	CcSEcCtD
Methylprednisolone—Nervous system disorder—Vincristine—sarcoma	0.000494	0.00151	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Mitoxantrone—sarcoma	0.00049	0.0015	CcSEcCtD
Methylprednisolone—Fatigue—Thiotepa—sarcoma	0.000489	0.0015	CcSEcCtD
Methylprednisolone—Infection—Mitoxantrone—sarcoma	0.000487	0.00149	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Vincristine—sarcoma	0.000487	0.00149	CcSEcCtD
Methylprednisolone—Fatigue—Dactinomycin—sarcoma	0.000486	0.00149	CcSEcCtD
Methylprednisolone—Shock—Mitoxantrone—sarcoma	0.000482	0.00148	CcSEcCtD
Methylprednisolone—Anaphylactoid reaction—Epirubicin—sarcoma	0.000481	0.00147	CcSEcCtD
Methylprednisolone—Tachycardia—Mitoxantrone—sarcoma	0.000478	0.00147	CcSEcCtD
Methylprednisolone—Cardiac failure—Epirubicin—sarcoma	0.000477	0.00146	CcSEcCtD
Methylprednisolone—Skin disorder—Mitoxantrone—sarcoma	0.000476	0.00146	CcSEcCtD
Methylprednisolone—Cardiac failure congestive—Doxorubicin—sarcoma	0.000474	0.00145	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Mitoxantrone—sarcoma	0.000474	0.00145	CcSEcCtD
Methylprednisolone—Hypotension—Vincristine—sarcoma	0.00047	0.00144	CcSEcCtD
Methylprednisolone—Feeling abnormal—Thiotepa—sarcoma	0.000468	0.00143	CcSEcCtD
Methylprednisolone—Osteoarthritis—Epirubicin—sarcoma	0.000465	0.00143	CcSEcCtD
Methylprednisolone—Feeling abnormal—Dactinomycin—sarcoma	0.000464	0.00142	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Thiotepa—sarcoma	0.000464	0.00142	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Etoposide—sarcoma	0.000464	0.00142	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Dactinomycin—sarcoma	0.000461	0.00141	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Vincristine—sarcoma	0.000459	0.00141	CcSEcCtD
Methylprednisolone—Hypotension—Mitoxantrone—sarcoma	0.000458	0.0014	CcSEcCtD
Methylprednisolone—Increased appetite—Doxorubicin—sarcoma	0.000458	0.0014	CcSEcCtD
Methylprednisolone—Affect lability—Epirubicin—sarcoma	0.000458	0.0014	CcSEcCtD
Methylprednisolone—Insomnia—Vincristine—sarcoma	0.000455	0.0014	CcSEcCtD
Methylprednisolone—Paraesthesia—Vincristine—sarcoma	0.000452	0.00139	CcSEcCtD
Methylprednisolone—Urticaria—Thiotepa—sarcoma	0.000451	0.00138	CcSEcCtD
Methylprednisolone—Malaise—Etoposide—sarcoma	0.000451	0.00138	CcSEcCtD
Methylprednisolone—Vertigo—Etoposide—sarcoma	0.000449	0.00138	CcSEcCtD
Methylprednisolone—Abdominal pain—Thiotepa—sarcoma	0.000449	0.00138	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000447	0.00137	CcSEcCtD
Methylprednisolone—Abdominal pain—Dactinomycin—sarcoma	0.000445	0.00136	CcSEcCtD
Methylprednisolone—Anaphylactoid reaction—Doxorubicin—sarcoma	0.000445	0.00136	CcSEcCtD
Methylprednisolone—Cardiac arrest—Epirubicin—sarcoma	0.000442	0.00136	CcSEcCtD
Methylprednisolone—Cardiac failure—Doxorubicin—sarcoma	0.000441	0.00135	CcSEcCtD
Methylprednisolone—Mood swings—Epirubicin—sarcoma	0.000441	0.00135	CcSEcCtD
Methylprednisolone—Paraesthesia—Mitoxantrone—sarcoma	0.00044	0.00135	CcSEcCtD
Methylprednisolone—Loss of consciousness—Etoposide—sarcoma	0.000439	0.00135	CcSEcCtD
Methylprednisolone—Fatigue—Vincristine—sarcoma	0.000434	0.00133	CcSEcCtD
Methylprednisolone—Convulsion—Etoposide—sarcoma	0.000433	0.00133	CcSEcCtD
Methylprednisolone—Dyspepsia—Mitoxantrone—sarcoma	0.000432	0.00132	CcSEcCtD
Methylprednisolone—Hypertension—Etoposide—sarcoma	0.000431	0.00132	CcSEcCtD
Methylprednisolone—Osteoarthritis—Doxorubicin—sarcoma	0.00043	0.00132	CcSEcCtD
Methylprednisolone—Affect lability—Doxorubicin—sarcoma	0.000424	0.0013	CcSEcCtD
Methylprednisolone—Fatigue—Mitoxantrone—sarcoma	0.000423	0.0013	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000422	0.00129	CcSEcCtD
Methylprednisolone—Discomfort—Etoposide—sarcoma	0.00042	0.00129	CcSEcCtD
Methylprednisolone—Breast disorder—Epirubicin—sarcoma	0.00042	0.00129	CcSEcCtD
Methylprednisolone—Hypersensitivity—Thiotepa—sarcoma	0.000418	0.00128	CcSEcCtD
Methylprednisolone—Hypersensitivity—Dactinomycin—sarcoma	0.000415	0.00127	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Vincristine—sarcoma	0.000412	0.00126	CcSEcCtD
Methylprednisolone—Confusional state—Etoposide—sarcoma	0.000411	0.00126	CcSEcCtD
Methylprednisolone—Alanine aminotransferase increased—Epirubicin—sarcoma	0.00041	0.00126	CcSEcCtD
Methylprednisolone—Muscular weakness—Epirubicin—sarcoma	0.00041	0.00126	CcSEcCtD
Methylprednisolone—Cardiac arrest—Doxorubicin—sarcoma	0.000409	0.00125	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Etoposide—sarcoma	0.000408	0.00125	CcSEcCtD
Methylprednisolone—Mood swings—Doxorubicin—sarcoma	0.000408	0.00125	CcSEcCtD
Methylprednisolone—Asthenia—Thiotepa—sarcoma	0.000407	0.00125	CcSEcCtD
Methylprednisolone—Infection—Etoposide—sarcoma	0.000405	0.00124	CcSEcCtD
Methylprednisolone—Abdominal distension—Epirubicin—sarcoma	0.000405	0.00124	CcSEcCtD
Methylprednisolone—Asthenia—Dactinomycin—sarcoma	0.000404	0.00124	CcSEcCtD
Methylprednisolone—Feeling abnormal—Mitoxantrone—sarcoma	0.000404	0.00124	CcSEcCtD
Methylprednisolone—Pruritus—Thiotepa—sarcoma	0.000402	0.00123	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000401	0.00123	CcSEcCtD
Methylprednisolone—Tachycardia—Etoposide—sarcoma	0.000398	0.00122	CcSEcCtD
Methylprednisolone—Abdominal pain—Vincristine—sarcoma	0.000398	0.00122	CcSEcCtD
Methylprednisolone—Skin disorder—Etoposide—sarcoma	0.000396	0.00121	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Etoposide—sarcoma	0.000394	0.00121	CcSEcCtD
Methylprednisolone—Pancreatitis—Epirubicin—sarcoma	0.000394	0.00121	CcSEcCtD
Methylprednisolone—Urticaria—Mitoxantrone—sarcoma	0.000389	0.00119	CcSEcCtD
Methylprednisolone—Breast disorder—Doxorubicin—sarcoma	0.000389	0.00119	CcSEcCtD
Methylprednisolone—Diarrhoea—Thiotepa—sarcoma	0.000388	0.00119	CcSEcCtD
Methylprednisolone—Abdominal pain—Mitoxantrone—sarcoma	0.000388	0.00119	CcSEcCtD
Methylprednisolone—Diarrhoea—Dactinomycin—sarcoma	0.000385	0.00118	CcSEcCtD
Methylprednisolone—Hypotension—Etoposide—sarcoma	0.000381	0.00117	CcSEcCtD
Methylprednisolone—Muscular weakness—Doxorubicin—sarcoma	0.00038	0.00116	CcSEcCtD
Methylprednisolone—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.00038	0.00116	CcSEcCtD
Methylprednisolone—Dizziness—Thiotepa—sarcoma	0.000375	0.00115	CcSEcCtD
Methylprednisolone—Abdominal distension—Doxorubicin—sarcoma	0.000374	0.00115	CcSEcCtD
Methylprednisolone—Hypersensitivity—Vincristine—sarcoma	0.000371	0.00114	CcSEcCtD
Methylprednisolone—Paraesthesia—Etoposide—sarcoma	0.000366	0.00112	CcSEcCtD
Methylprednisolone—Weight increased—Epirubicin—sarcoma	0.000366	0.00112	CcSEcCtD
Methylprednisolone—Pancreatitis—Doxorubicin—sarcoma	0.000365	0.00112	CcSEcCtD
Methylprednisolone—Hypersensitivity—Mitoxantrone—sarcoma	0.000361	0.00111	CcSEcCtD
Methylprednisolone—Asthenia—Vincristine—sarcoma	0.000361	0.00111	CcSEcCtD
Methylprednisolone—Vomiting—Thiotepa—sarcoma	0.000361	0.00111	CcSEcCtD
Methylprednisolone—Infestation NOS—Epirubicin—sarcoma	0.000358	0.0011	CcSEcCtD
Methylprednisolone—Infestation—Epirubicin—sarcoma	0.000358	0.0011	CcSEcCtD
Methylprednisolone—Vomiting—Dactinomycin—sarcoma	0.000358	0.0011	CcSEcCtD
Methylprednisolone—Rash—Thiotepa—sarcoma	0.000358	0.0011	CcSEcCtD
Methylprednisolone—Dermatitis—Thiotepa—sarcoma	0.000358	0.0011	CcSEcCtD
Methylprednisolone—Headache—Thiotepa—sarcoma	0.000356	0.00109	CcSEcCtD
Methylprednisolone—Rash—Dactinomycin—sarcoma	0.000355	0.00109	CcSEcCtD
Methylprednisolone—Asthenia—Mitoxantrone—sarcoma	0.000352	0.00108	CcSEcCtD
Methylprednisolone—Fatigue—Etoposide—sarcoma	0.000352	0.00108	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Epirubicin—sarcoma	0.000351	0.00108	CcSEcCtD
Methylprednisolone—Diarrhoea—Vincristine—sarcoma	0.000344	0.00106	CcSEcCtD
Methylprednisolone—Sweating—Epirubicin—sarcoma	0.000344	0.00105	CcSEcCtD
Methylprednisolone—Weight increased—Doxorubicin—sarcoma	0.000338	0.00104	CcSEcCtD
Methylprednisolone—Nausea—Thiotepa—sarcoma	0.000337	0.00103	CcSEcCtD
Methylprednisolone—Feeling abnormal—Etoposide—sarcoma	0.000336	0.00103	CcSEcCtD
Methylprednisolone—Diarrhoea—Mitoxantrone—sarcoma	0.000335	0.00103	CcSEcCtD
Methylprednisolone—Nausea—Dactinomycin—sarcoma	0.000335	0.00103	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Etoposide—sarcoma	0.000333	0.00102	CcSEcCtD
Methylprednisolone—Dizziness—Vincristine—sarcoma	0.000333	0.00102	CcSEcCtD
Methylprednisolone—Infestation NOS—Doxorubicin—sarcoma	0.000332	0.00102	CcSEcCtD
Methylprednisolone—Infestation—Doxorubicin—sarcoma	0.000332	0.00102	CcSEcCtD
Methylprednisolone—Bradycardia—Epirubicin—sarcoma	0.000328	0.001	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Doxorubicin—sarcoma	0.000325	0.000996	CcSEcCtD
Methylprednisolone—Urticaria—Etoposide—sarcoma	0.000324	0.000993	CcSEcCtD
Methylprednisolone—Haemoglobin—Epirubicin—sarcoma	0.000323	0.000991	CcSEcCtD
Methylprednisolone—Rhinitis—Epirubicin—sarcoma	0.000323	0.000988	CcSEcCtD
Methylprednisolone—Abdominal pain—Etoposide—sarcoma	0.000322	0.000988	CcSEcCtD
Methylprednisolone—Haemorrhage—Epirubicin—sarcoma	0.000322	0.000986	CcSEcCtD
Methylprednisolone—Vomiting—Vincristine—sarcoma	0.00032	0.000981	CcSEcCtD
Methylprednisolone—Sweating—Doxorubicin—sarcoma	0.000318	0.000974	CcSEcCtD
Methylprednisolone—Rash—Vincristine—sarcoma	0.000317	0.000973	CcSEcCtD
Methylprednisolone—Dermatitis—Vincristine—sarcoma	0.000317	0.000972	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Epirubicin—sarcoma	0.000316	0.000969	CcSEcCtD
Methylprednisolone—Headache—Vincristine—sarcoma	0.000315	0.000966	CcSEcCtD
Methylprednisolone—Vomiting—Mitoxantrone—sarcoma	0.000312	0.000955	CcSEcCtD
Methylprednisolone—Visual impairment—Epirubicin—sarcoma	0.00031	0.00095	CcSEcCtD
Methylprednisolone—Rash—Mitoxantrone—sarcoma	0.000309	0.000947	CcSEcCtD
Methylprednisolone—Dermatitis—Mitoxantrone—sarcoma	0.000309	0.000946	CcSEcCtD
Methylprednisolone—Headache—Mitoxantrone—sarcoma	0.000307	0.000941	CcSEcCtD
Methylprednisolone—Bradycardia—Doxorubicin—sarcoma	0.000303	0.000929	CcSEcCtD
Methylprednisolone—Eye disorder—Epirubicin—sarcoma	0.000301	0.000921	CcSEcCtD
Methylprednisolone—Hypersensitivity—Etoposide—sarcoma	0.0003	0.000921	CcSEcCtD
Methylprednisolone—Haemoglobin—Doxorubicin—sarcoma	0.000299	0.000917	CcSEcCtD
Methylprednisolone—Nausea—Vincristine—sarcoma	0.000299	0.000916	CcSEcCtD
Methylprednisolone—Cardiac disorder—Epirubicin—sarcoma	0.000299	0.000915	CcSEcCtD
Methylprednisolone—Rhinitis—Doxorubicin—sarcoma	0.000298	0.000915	CcSEcCtD
Methylprednisolone—Haemorrhage—Doxorubicin—sarcoma	0.000298	0.000912	CcSEcCtD
Methylprednisolone—Asthenia—Etoposide—sarcoma	0.000293	0.000896	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Doxorubicin—sarcoma	0.000293	0.000896	CcSEcCtD
Methylprednisolone—Angiopathy—Epirubicin—sarcoma	0.000292	0.000894	CcSEcCtD
Methylprednisolone—Nausea—Mitoxantrone—sarcoma	0.000291	0.000892	CcSEcCtD
Methylprednisolone—Immune system disorder—Epirubicin—sarcoma	0.000291	0.00089	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Epirubicin—sarcoma	0.00029	0.000889	CcSEcCtD
Methylprednisolone—Pruritus—Etoposide—sarcoma	0.000288	0.000884	CcSEcCtD
Methylprednisolone—Arrhythmia—Epirubicin—sarcoma	0.000287	0.000881	CcSEcCtD
Methylprednisolone—Visual impairment—Doxorubicin—sarcoma	0.000287	0.000879	CcSEcCtD
Methylprednisolone—Mental disorder—Epirubicin—sarcoma	0.000282	0.000864	CcSEcCtD
Methylprednisolone—Erythema—Epirubicin—sarcoma	0.00028	0.000858	CcSEcCtD
Methylprednisolone—Malnutrition—Epirubicin—sarcoma	0.00028	0.000858	CcSEcCtD
Methylprednisolone—Diarrhoea—Etoposide—sarcoma	0.000279	0.000855	CcSEcCtD
Methylprednisolone—Eye disorder—Doxorubicin—sarcoma	0.000278	0.000852	CcSEcCtD
Methylprednisolone—Cardiac disorder—Doxorubicin—sarcoma	0.000276	0.000847	CcSEcCtD
Methylprednisolone—Angiopathy—Doxorubicin—sarcoma	0.00027	0.000828	CcSEcCtD
Methylprednisolone—Dizziness—Etoposide—sarcoma	0.00027	0.000826	CcSEcCtD
Methylprednisolone—Immune system disorder—Doxorubicin—sarcoma	0.000269	0.000824	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Doxorubicin—sarcoma	0.000268	0.000822	CcSEcCtD
Methylprednisolone—Arrhythmia—Doxorubicin—sarcoma	0.000266	0.000815	CcSEcCtD
Methylprednisolone—Mental disorder—Doxorubicin—sarcoma	0.000261	0.000799	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Epirubicin—sarcoma	0.00026	0.000796	CcSEcCtD
Methylprednisolone—Vomiting—Etoposide—sarcoma	0.000259	0.000794	CcSEcCtD
Methylprednisolone—Malnutrition—Doxorubicin—sarcoma	0.000259	0.000794	CcSEcCtD
Methylprednisolone—Erythema—Doxorubicin—sarcoma	0.000259	0.000794	CcSEcCtD
Methylprednisolone—Rash—Etoposide—sarcoma	0.000257	0.000788	CcSEcCtD
Methylprednisolone—Dermatitis—Etoposide—sarcoma	0.000257	0.000787	CcSEcCtD
Methylprednisolone—Headache—Etoposide—sarcoma	0.000255	0.000783	CcSEcCtD
Methylprednisolone—Malaise—Epirubicin—sarcoma	0.000253	0.000774	CcSEcCtD
Methylprednisolone—Vertigo—Epirubicin—sarcoma	0.000252	0.000771	CcSEcCtD
Methylprednisolone—Syncope—Epirubicin—sarcoma	0.000251	0.00077	CcSEcCtD
Methylprednisolone—Loss of consciousness—Epirubicin—sarcoma	0.000246	0.000754	CcSEcCtD
Methylprednisolone—Convulsion—Epirubicin—sarcoma	0.000243	0.000744	CcSEcCtD
Methylprednisolone—Nausea—Etoposide—sarcoma	0.000242	0.000742	CcSEcCtD
Methylprednisolone—Hypertension—Epirubicin—sarcoma	0.000242	0.000741	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Doxorubicin—sarcoma	0.00024	0.000737	CcSEcCtD
Methylprednisolone—Arthralgia—Epirubicin—sarcoma	0.000238	0.000731	CcSEcCtD
Methylprednisolone—Myalgia—Epirubicin—sarcoma	0.000238	0.000731	CcSEcCtD
Methylprednisolone—Anxiety—Epirubicin—sarcoma	0.000238	0.000728	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000237	0.000726	CcSEcCtD
Methylprednisolone—Discomfort—Epirubicin—sarcoma	0.000236	0.000722	CcSEcCtD
Methylprednisolone—Malaise—Doxorubicin—sarcoma	0.000234	0.000716	CcSEcCtD
Methylprednisolone—Vertigo—Doxorubicin—sarcoma	0.000233	0.000713	CcSEcCtD
Methylprednisolone—Syncope—Doxorubicin—sarcoma	0.000232	0.000712	CcSEcCtD
Methylprednisolone—Confusional state—Epirubicin—sarcoma	0.00023	0.000706	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Epirubicin—sarcoma	0.000229	0.0007	CcSEcCtD
Methylprednisolone—Loss of consciousness—Doxorubicin—sarcoma	0.000228	0.000698	CcSEcCtD
Methylprednisolone—Infection—Epirubicin—sarcoma	0.000227	0.000696	CcSEcCtD
Methylprednisolone—Shock—Epirubicin—sarcoma	0.000225	0.000689	CcSEcCtD
Methylprednisolone—Convulsion—Doxorubicin—sarcoma	0.000225	0.000688	CcSEcCtD
Methylprednisolone—Nervous system disorder—Epirubicin—sarcoma	0.000224	0.000687	CcSEcCtD
Methylprednisolone—Hypertension—Doxorubicin—sarcoma	0.000224	0.000686	CcSEcCtD
Methylprednisolone—Tachycardia—Epirubicin—sarcoma	0.000223	0.000684	CcSEcCtD
Methylprednisolone—Skin disorder—Epirubicin—sarcoma	0.000222	0.00068	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Epirubicin—sarcoma	0.000221	0.000677	CcSEcCtD
Methylprednisolone—Arthralgia—Doxorubicin—sarcoma	0.000221	0.000676	CcSEcCtD
Methylprednisolone—Myalgia—Doxorubicin—sarcoma	0.000221	0.000676	CcSEcCtD
Methylprednisolone—Anxiety—Doxorubicin—sarcoma	0.00022	0.000674	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000219	0.000671	CcSEcCtD
Methylprednisolone—Discomfort—Doxorubicin—sarcoma	0.000218	0.000668	CcSEcCtD
Methylprednisolone—Hypotension—Epirubicin—sarcoma	0.000214	0.000654	CcSEcCtD
Methylprednisolone—Confusional state—Doxorubicin—sarcoma	0.000213	0.000653	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Doxorubicin—sarcoma	0.000211	0.000648	CcSEcCtD
Methylprednisolone—Infection—Doxorubicin—sarcoma	0.00021	0.000644	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000208	0.000638	CcSEcCtD
Methylprednisolone—Shock—Doxorubicin—sarcoma	0.000208	0.000638	CcSEcCtD
Methylprednisolone—Nervous system disorder—Doxorubicin—sarcoma	0.000207	0.000636	CcSEcCtD
Methylprednisolone—Insomnia—Epirubicin—sarcoma	0.000207	0.000633	CcSEcCtD
Methylprednisolone—Tachycardia—Doxorubicin—sarcoma	0.000206	0.000633	CcSEcCtD
Methylprednisolone—Skin disorder—Doxorubicin—sarcoma	0.000205	0.000629	CcSEcCtD
Methylprednisolone—Paraesthesia—Epirubicin—sarcoma	0.000205	0.000629	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Doxorubicin—sarcoma	0.000204	0.000627	CcSEcCtD
Methylprednisolone—Dyspepsia—Epirubicin—sarcoma	0.000201	0.000617	CcSEcCtD
Methylprednisolone—Hypotension—Doxorubicin—sarcoma	0.000198	0.000606	CcSEcCtD
Methylprednisolone—Fatigue—Epirubicin—sarcoma	0.000197	0.000604	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000193	0.00059	CcSEcCtD
Methylprednisolone—Insomnia—Doxorubicin—sarcoma	0.000191	0.000586	CcSEcCtD
Methylprednisolone—Paraesthesia—Doxorubicin—sarcoma	0.00019	0.000582	CcSEcCtD
Methylprednisolone—Feeling abnormal—Epirubicin—sarcoma	0.000188	0.000577	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Epirubicin—sarcoma	0.000187	0.000573	CcSEcCtD
Methylprednisolone—Dyspepsia—Doxorubicin—sarcoma	0.000186	0.00057	CcSEcCtD
Methylprednisolone—Fatigue—Doxorubicin—sarcoma	0.000182	0.000559	CcSEcCtD
Methylprednisolone—Urticaria—Epirubicin—sarcoma	0.000182	0.000556	CcSEcCtD
Methylprednisolone—Abdominal pain—Epirubicin—sarcoma	0.000181	0.000554	CcSEcCtD
Methylprednisolone—Feeling abnormal—Doxorubicin—sarcoma	0.000174	0.000534	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Doxorubicin—sarcoma	0.000173	0.00053	CcSEcCtD
Methylprednisolone—Hypersensitivity—Epirubicin—sarcoma	0.000168	0.000516	CcSEcCtD
Methylprednisolone—Urticaria—Doxorubicin—sarcoma	0.000168	0.000515	CcSEcCtD
Methylprednisolone—Abdominal pain—Doxorubicin—sarcoma	0.000167	0.000512	CcSEcCtD
Methylprednisolone—Asthenia—Epirubicin—sarcoma	0.000164	0.000503	CcSEcCtD
Methylprednisolone—Pruritus—Epirubicin—sarcoma	0.000162	0.000496	CcSEcCtD
Methylprednisolone—Diarrhoea—Epirubicin—sarcoma	0.000156	0.000479	CcSEcCtD
Methylprednisolone—Hypersensitivity—Doxorubicin—sarcoma	0.000156	0.000477	CcSEcCtD
Methylprednisolone—Asthenia—Doxorubicin—sarcoma	0.000152	0.000465	CcSEcCtD
Methylprednisolone—Dizziness—Epirubicin—sarcoma	0.000151	0.000463	CcSEcCtD
Methylprednisolone—Pruritus—Doxorubicin—sarcoma	0.00015	0.000459	CcSEcCtD
Methylprednisolone—Vomiting—Epirubicin—sarcoma	0.000145	0.000445	CcSEcCtD
Methylprednisolone—Diarrhoea—Doxorubicin—sarcoma	0.000145	0.000443	CcSEcCtD
Methylprednisolone—Rash—Epirubicin—sarcoma	0.000144	0.000442	CcSEcCtD
Methylprednisolone—Dermatitis—Epirubicin—sarcoma	0.000144	0.000441	CcSEcCtD
Methylprednisolone—Headache—Epirubicin—sarcoma	0.000143	0.000439	CcSEcCtD
Methylprednisolone—Dizziness—Doxorubicin—sarcoma	0.00014	0.000429	CcSEcCtD
Methylprednisolone—Nausea—Epirubicin—sarcoma	0.000136	0.000416	CcSEcCtD
Methylprednisolone—Vomiting—Doxorubicin—sarcoma	0.000134	0.000412	CcSEcCtD
Methylprednisolone—Rash—Doxorubicin—sarcoma	0.000133	0.000409	CcSEcCtD
Methylprednisolone—Dermatitis—Doxorubicin—sarcoma	0.000133	0.000408	CcSEcCtD
Methylprednisolone—Headache—Doxorubicin—sarcoma	0.000132	0.000406	CcSEcCtD
Methylprednisolone—Nausea—Doxorubicin—sarcoma	0.000126	0.000385	CcSEcCtD
